- Home
- OMIC
as 12-18-2024 2:40pm EST
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 34.9M | IPO Year: | 2021 |
| Target Price: | $10.75 | AVG Volume (30 days): | 12.2K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -34.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.34 - $23.41 | Next Earning Date: | 11-12-2024 |
| Revenue: | $2,667,000 | Revenue Growth: | 2.77% |
| Revenue Growth (this year): | 3.98% | Revenue Growth (next year): | 242.05% |
Stock Insider Trading Activity of Singular Genomics Systems Inc. (OMIC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Spaventa Andrew | OMIC | Chief Executive Officer | Dec 15 '24 | Sell | $20.16 | 180 | $3,629.11 | 631 | |
| Spaventa Andrew | OMIC | Chief Executive Officer | Nov 12 '24 | Sell | $22.55 | 695 | $15,668.78 | 631 |
Latest Singular Genomics Systems Inc. News
OMIC Breaking Stock News: Dive into OMIC Ticker-Specific Updates for Smart Investing
Associated Press Finance
a month ago
Similar Genomics Systems: Q3 Earnings Snapshot
GlobeNewswire
a month ago
Singular Genomics Reports Recent Updates and Third Quarter 2024 Financial Results
GuruFocus.com
a month ago
OMIC Faces Uncertainty of Share Purchase Offers From Concerta, Tang and Deerfield
MT Newswires
a month ago
Top Premarket Gainers
MT Newswires
3 months ago
Singular Genomics Systems Discloses $12 per Share Acquisition Bid From Concentra Biosciences
GlobeNewswire
3 months ago
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
GuruFocus.com
3 months ago
TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Singular Genomics Systems Inc
MT Newswires
3 months ago
Singular Genomics Systems Insider Bought Shares Worth $1,806,220, According to a Recent SEC Filing
Compare OMIC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OMIC Singular Genomics Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.